Morgan Stanley Knock-Out ABL/ DE000MC8DSK9 /
15/05/2024 19:53:09 | Chg.+0.05 | Bid20:53:58 | Ask20:53:58 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.49EUR | +3.47% | 1.49 Bid Size: 40,000 |
1.50 Ask Size: 40,000 |
ABBOTT LABS | 88.5269 - | 31/12/2078 | Call |
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
02/10/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
06/09/2023
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region